Yamaguchi Y, Flier J S, Benecke H, Ransil B J, Moller D E
Charles A. Dana Research Institute, Harvard-Thorndike Laboratory, Beth Israel Hospital, Boston, Massachusetts 02215.
Endocrinology. 1993 Mar;132(3):1132-8. doi: 10.1210/endo.132.3.8440175.
Tissue-specific alternative splicing of exon 11 of the insulin receptor gene results in 2 mRNAs that differ by 36 nucleotides within the coding region. The 2 transcripts encode 2 protein isoforms with (Ex11+) or without (Ex11-) 12 additional amino acids at the carboxy-terminus of the receptor alpha-subunit. Previous studies of the 2 isoforms of the human insulin receptor expressed in mammalian cell transfectants have revealed small functional differences at the levels of equilibrium insulin binding affinity and acute ligand-induced receptor internalization. In the present study, we determined the biochemical basis for differential insulin binding affinity. Further functional characterization of the 2 receptor isoforms was also performed. The results obtained were as follows. 1) Studies of ligand association demonstrated a faster (1.8-fold) "on rate" for Ex11- receptors than for Ex11+ receptors, as determined by the kinetics of [125I]insulin binding to transfected cells. In addition, dissociation of prebound [125I]insulin from Ex11- receptors was characterized by an accelerated "off rate" relative to that of Ex11+ receptors. 2) Using both intact Chinese hamster ovary (CHO) cells and partially purified solubilized insulin receptors, the ability of insulin-like growth factor-I to compete for [125I]insulin binding to either isoform differed markedly. The mean IC50 for Ex11- was 40 nM vs. 350 nM for Ex11+. 3) Both Ex11- and Ex11+ receptors were equally capable of hybrid formation with endogenous CHO cell insulin-like growth factor-I receptors. 4) The relative abilities of 2 inhibitory polyclonal antiinsulin receptor antisera to displace [125I]insulin binding did not differ between the two isoforms. 5) Studies of insulin-induced (300 nM) receptor down-regulation in CHO cell transfectants suggested preferential down-regulation of Ex11- receptors; however, no down-regulation difference was observed when Rat 1 cell transfectants expressing the two splice variants were studied. These findings further support the idea that the 2 isoforms of the insulin receptor are functionally distinct in important ways.
胰岛素受体基因外显子11的组织特异性可变剪接产生了2种mRNA,它们在编码区域内相差36个核苷酸。这2种转录本编码2种蛋白质异构体,在受体α亚基的羧基末端有(Ex11+)或没有(Ex11-)额外的12个氨基酸。先前对在哺乳动物细胞转染子中表达的人胰岛素受体的2种异构体的研究表明,在平衡胰岛素结合亲和力和急性配体诱导的受体内化水平上存在微小的功能差异。在本研究中,我们确定了胰岛素结合亲和力差异的生化基础。还对这2种受体异构体进行了进一步的功能表征。获得的结果如下。1)配体结合研究表明,通过[125I]胰岛素与转染细胞结合的动力学测定,Ex11-受体的“结合速率”比Ex11+受体快(1.8倍)。此外,与Ex11+受体相比,预结合的[125I]胰岛素从Ex11-受体上解离的特征是“解离速率”加快。2)使用完整的中国仓鼠卵巢(CHO)细胞和部分纯化的可溶性胰岛素受体,胰岛素样生长因子-I竞争[125I]胰岛素与任一异构体结合的能力有显著差异。Ex11-的平均IC50为40 nM,而Ex11+为350 nM。3)Ex11-和Ex11+受体与内源性CHO细胞胰岛素样生长因子-I受体形成杂交体的能力相同。4)两种抑制性多克隆抗胰岛素受体抗血清置换[125I]胰岛素结合的相对能力在两种异构体之间没有差异。5)对CHO细胞转染子中胰岛素诱导(300 nM)的受体下调的研究表明,Ex11-受体优先下调;然而,在研究表达两种剪接变体的大鼠1细胞转染子时,未观察到下调差异。这些发现进一步支持了胰岛素受体的2种异构体在重要方面功能不同的观点。